March 25 (Reuters) – A bipartisan group of U.S. senators has reached a deal on capping the price of a month’s supply of insulin at $35, Semafor reported on Wednesday, citing an interview with New Hampshire Democrat Senator Jeanne Shaheen.
Shaheen is making an urgent push to pass legislation to reduce the cost of insulin before her retirement from Congress, teaming with Senators Susan Collins, Raphael Warnock and John Kennedy, according to the Semafor report.
(Reporting by Rishabh Jaiswal in Bengaluru; Editing by Andrew Heavens)
Comments